Zymergen Inc.

NASDAQ: ZY · Real-Time Price · USD
2.43
0.00 (0.00%)
At close: Oct 18, 2022, 10:00 PM

Zymergen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
16.74M
Cost of Revenue
69.72M
Gross Profit
-52.98M
Operating Income
-347.03M
Interest Income
64K
Pretax Income
-361.73M
Net Income
-361.79M
Selling & General & Admin
106.66M
Research & Development
159.12M
Other Expenses
n/a
Operating Expenses
265.78M
Interest Expense
14.71M
Selling & Marketing Expenses
23.65M
Cost & Expenses
335.5M
Income Tax Expense
51K
Shares Outstanding (Basic)
74.31M
Shares Outstanding (Diluted)
74.31M
EPS (Basic)
-4.87
EPS (Diluted)
-4.87
EBITDA
-326.33M
EBIT
-346.5M
Depreciation & Amortization
20.7M